COMPARABILITY OF POPULATION DEFINITIONS WITHIN & BETWEEN GLOBAL DATABASES – DEVELOPING TOOLS FOR OBSERVATIONAL RESEARCH (ACO Population Definitions)

15/07/2016
02/07/2024
EU PAS number:
EUPAS13959
Study
Finalised
Study type

Study topic

Disease /health condition

Study type

Non-interventional study

Scope of the study

Disease epidemiology

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Observational, historical database study
Study drug and medical condition

Medical condition to be studied

Chronic obstructive pulmonary disease
Asthma
Asthma-chronic obstructive pulmonary disease overlap syndrome
Population studied

Short description of the study population

Chronic obstructive pulmonary disease, Asthma, and Asthma-chronic obstructive pulmonary disease overlap syndrome patients

Age groups

  • Children (2 to < 12 years)
  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

50000
Study design details

Main study objective

To inform standardised methods for future ACO observational research, the study aims to: test various smoking-related ACO population definitions (based on previous evidence), evaluating their respective prevalence and agreement (i) within and (ii) between a number of national and international research quality databases

Outcomes

The primary outcomes of the study are the prevalence of subpopulations B and C, relative to A within each of the parent population series (COPD, ACOS, Asthma, Control) and the agreement within each database between the most selective subpopulations’ definitions within each parent series (i.e. subpopulation C) and between different databases

Data analysis plan

Evaluation of:1. Outcome 1 (total number of patients) will require absolute count of patient numbers.2. Outcome 2 (population prevalence) will require evaluation of the percent prevalence within different Parent Series.3. Outcomes 3 & 4 (agreement across different population definitions: 1C vs 2C vs 3C vs 4C) will use the kappa statistic (k) or suitable alternatives (e.g. Chi-squared)